Skip to main content
Glama

Resolve Entity

resolve_entity
Read-onlyIdempotent

"What's the ticker for…" / "find the CIK for…" / "what's the LEI for…" / "what's the RxCUI for…" / "look up the ID for…" / "what is X's official identifier" / "who owns X" / "is X a subsidiary of Y" — resolve a user-spoken NAME to the canonical/official identifiers other tools require as input. Use FIRST whenever you have a name but need an ID. SUPPORTED TYPES: "company" (cross-source identity spine: 10-digit CIK + ticker + company_name from SEC EDGAR, legal-entity LEI from GLEIF with parent/ultimate-parent/children ownership when the LEI resolves, and security FIGI from OpenFIGI — by exact ticker map when a ticker is implied, and otherwise by name search, so NON-EQUITY instruments that never have a ticker (municipal and corporate bonds, notes, authority debt) DO resolve here; when a name matches more than one instrument it asserts nothing and returns figi_candidates to pick from, which is the correct answer to an issuer name that does not identify a single bond; every identifier is labelled with the source that established it, and an identifier that could NOT be resolved is stated explicitly under unresolved rather than omitted — accepts ticker, CIK, ISIN, or company name as input; an ISIN like "CH0038863350" resolves to the LEGAL ENTITY that issued the security via the GLEIF ISIN-to-LEI mapping, covering non-US issuers EDGAR cannot reach), "drug" (returns RxCUI + ingredient + brand from RxNorm + pipeworx://rxnorm/concept/{rxcui} citation; accepts brand or generic name). LEI/FIGI enrichment degrades gracefully — if GLEIF or OpenFIGI is unavailable, the EDGAR identifiers still return. Each call cascades through several lookup endpoints internally — using resolve_entity replaces 2-3 manual lookups.

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
typeYesEntity type: "company" or "drug".
valueYesFor company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., "ozempic", "metformin"). Pass the ENTITY NAME ONLY — for a bond that is the ISSUER exactly as printed ("NEW YORK ST DORM AUTH"), never the question's full noun phrase ("NEW YORK ST DORM AUTH revenue bonds"): the FIGI lookup matches instrument names, so trailing security-class words match nothing.

Schema Changelog

Changes observed during successful MCP inspections. Dates show when Glama detected each change.

  1. Changed1 schema field changed
    • changedInput schema / properties / value / description
      Previous value: -"For company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., \"ozempic\", \"metformin\")."New value: +"For company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., \"ozempic\", \"metformin\"). Pass the ENTITY NAME ONLY — for a bond that is the ISSUER exactly as printed (\"NEW YORK ST DORM AUTH\"), never the question's full noun phrase (\"NEW YORK ST DORM AUTH revenue bonds\"): the FIGI lookup matches instrument names, so trailing security-class words match nothing."
  2. First observed

TDQS

A4.5/5.0
Behavior5/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Annotations already mark this as read-only, open-world, and idempotent, and the description adds substantial context: identifier sourcing, explicit `unresolved` output, graceful degradation for LEI/FIGI, internal cascading across endpoints, and ambiguous matches returning `figi_candidates`. This goes well beyond the annotations and clarifies exactly how the tool behaves.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness4/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The description is long but well-structured: example queries come first, followed by usage guidance, then per-type details. Almost every sentence adds information, though some redundancy with the schema and the very long parenthetical could be tightened without losing meaning.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness5/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

Despite lacking an output schema, the description explains what will be returned for both supported types, how sources are labeled, what happens on ambiguous matches, and how failures are surfaced (`unresolved`). Combined with annotations, an agent has enough context to select and invoke the tool correctly.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters5/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema coverage is 100%, but the description adds critical value beyond the schema: it explains the 'entity name only' rule, warns that trailing security-class words will not match in FIGI lookups, gives examples of accepted inputs (ticker, CIK, ISIN, brand/generic names), and clarifies ISIN-to-LEI behavior. This materially improves correct invocation.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose4/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description specifies the verb 'resolve' and the resource: user-spoken names to canonical identifiers required by other tools, with example queries and supported types. It does not explicitly name a sibling tool to distinguish from (e.g., entity_profile), so it is clear but lacks direct sibling differentiation.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines4/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

The description gives a clear directive: 'Use FIRST whenever you have a name but need an ID,' and adds that one call replaces 2-3 manual lookups. It does not explicitly say when not to use this tool or name an alternative, so it stops short of the strongest when-to-use guidance.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

Try in Browser

Glama MCP Gateway

Add one secure layer between your agents and this server.

TDQS

A3.6/5.0
Disambiguation1/5

ask_pipeworx and ask_pipeworx_beta are currently identical, deep_research overlaps ask_pipeworx for multi-faceted questions, and the five Polymarket tools plus bet_research all target the same market-analysis space. Several tools appear to do the same thing, and even detailed descriptions can't fully separate them.

Naming Consistency3/5

All names are lowercase snake_case and mostly readable, but the set mixes bare nouns (datasets, query, recall) with verb phrases (generate_llms_txt, validate_claim) and domain-prefixed compounds (polymarket_edges, pipeworx_trending). The ask_pipeworx family is internally consistent, but the overall pattern is not uniform.

Tool Count2/5

34 tools is well above the 25-tool threshold for a coherent set, especially since many are meta-tools (suggest_questions, discover_tools, pipeworx_feedback, pipeworx_trending) or one-off utilities (generate_llms_txt, scan_dependency). The server tries to cover data lookup, prediction markets, memory, subscriptions, and AI visibility in a single surface.

Completeness3/5

Within each subdomain (data lookup, memory, subscriptions, Polymarket) the main workflows are covered, and the memory/subscription clusters have full CRUD. But the server name promises Norfolk Open Data, which is barely represented by three read-only tools, and odd one-offs like generate_llms_txt and scan_dependency have no supporting ecosystem.